Safety and efficacy outcomes of overlapping second-generation everolimus-eluting stents versus first-generation drug-eluting stents

American Journal of Cardiology

Volumn 112, Issue 8, 2013, Pages 1093-1098

  Kitabata, Hironori ^a   Loh, Joshua P ^a   Pendyala, Lakshmana K ^a   Badr, Salem ^a   Dvir, Danny ^a   Barbash, Israel M ^a   Minha, Sa'Ar ^a   Torguson, Rebecca ^a   Chen, Fang ^a   Satler, Lowell F ^a   Suddath, William O ^a   Kent, Kenneth M ^a   Pichard, Augusto D ^a   Waksman, Ron ^a  

^a WASHINGTON HOSPITAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; EVEROLIMUS; FIBRINOGEN RECEPTOR ANTAGONIST; PACLITAXEL; PRASUGREL; THIENOPYRIDINE DERIVATIVE;

ADULT; AGED; ARTICLE; DEATH; DRUG ELUTING STENT; FEMALE; FOLLOW UP; HEART INFARCTION; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; STENT THROMBOSIS; TREATMENT OUTCOME;

AGED; ANTINEOPLASTIC AGENTS, PHYTOGENIC; CORONARY ARTERY DISEASE; DISTRICT OF COLUMBIA; DRUG-ELUTING STENTS; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INCIDENCE; MALE; MIDDLE AGED; PACLITAXEL; POSTOPERATIVE COMPLICATIONS; PROSTHESIS DESIGN; RETROSPECTIVE STUDIES; SIROLIMUS; TREATMENT OUTCOME;

EID: 84884907552     PISSN: 00029149     EISSN: 18791913     Source Type: Journal    
DOI: 10.1016/j.amjcard.2013.05.054     Document Type: Article

References (27)

1. A. Kastrati, J. Mehilli, J. Pache, C. Kaiser, M. Valgimigli, H. Kelbaek, M. Menichelli, M. Sabaté, M.J. Suttorp, D. Baumgart, M. Seyfarth, M.E. Pfisterer, and A. Schömig An analysis of 14 trials comparing sirolimus-eluting stents with bare-metal stents N Engl J Med 356 2007 1030 1039
2. G.W. Stone, J.W. Moses, S.G. Ellis, J. Schofer, K.D. Dawkins, M.C. Morice, A. Colombo, E. Schampaert, E. Grube, A.J. Kirtane, D.E. Cutlip, M. Fahy, S.J. Pocock, R. Mehran, and M.B. Leon Safety and efficacy of sirolimus- and paclitaxel-eluting coronary stents N Engl J Med 356 2007 998 1008
3. D.J. Clark, M.C. Wong, R.K. Chan, L.E. Oliver, and A.E. Ajani Very late drug-eluting stent thrombosis Cardiovasc Revasc Med 8 2007 72 75
4. V. Aytekin, R. Erdim, S. Gormez, and C. Demiroglu Very late thrombosis of paclitaxel-eluting stent Cardiovasc Revasc Med 9 2008 275 277
5. A.V. Finn, G. Nakazawa, M. Joner, F.D. Kolodgie, E.K. Mont, H.K. Gold, and R. Virmani Vascular responses to drug eluting stents: importance of delayed healing Arterioscler Thromb Vasc Biol 27 2007 1500 1510
6. A.V. Finn, F.D. Kolodgie, J. Harnek, L.J. Guerrero, E. Acampado, K. Tefera, K. Skorija, D.K. Weber, H.K. Gold, and R. Virmani Differential response of delayed healing and persistent inflammation at sites of overlapping sirolimus- or paclitaxel-eluting stents Circulation 112 2005 270 278
7. L. Räber, P. Jüni, L. Löffel, S. Wandel, S. Cook, P. Wenaweser, M. Togni, R. Vogel, C. Seiler, F. Eberli, T. Lüscher, B. Meier, and S. Windecker Impact of stent overlap on angiographic and long-term clinical outcome in patients undergoing drug-eluting stent implantation J Am Coll Cardiol 55 2010 1178 1188
8. J. Aoki, A.T. Ong, G.A. Rodriguez Granillo, E.P. McFadden, C.A. van Mieghem, M. Valgimigli, K. Tsuchida, G. Sianos, E. Regar, P.P. de Jaegere, W.J. van der Giessen, P.J. de Feyter, R.T. van Domburg, and P.W. Serruys "Full metal jacket" (stented length > or =64 mm) using drug-eluting stents for de novo coronary artery lesions Am Heart J 150 2005 994 999
9. E. Tsagalou, A. Chieffo, I. Iakovou, L. Ge, G.M. Sangiorgi, N. Corvaja, F. Airoldi, M. Montorfano, I. Michev, and A. Colombo Multiple overlapping drug-eluting stents to treat diffuse disease of the left anterior descending coronary artery J Am Coll Cardiol 45 2005 1570 1573
10. D.J. Kereiakes, H. Wang, J.J. Popma, R.E. Kuntz, D.J. Donohoe, J. Schofer, E. Schampaert, B. Meier, M.B. Leon, and J.W. Moses Periprocedural and late consequences of overlapping Cypher sirolimus-eluting stents: pooled analysis of five clinical trials J Am Coll Cardiol 48 2006 21 31
11. W.W. Chu, P.K. Kuchulakanti, R. Torguson, B. Wang, L.C. Clavijo, W.O. Suddath, A.D. Pichard, L.F. Satler, K.M. Kent, and R. Waksman Comparison of clinical outcomes of overlapping sirolimus- versus paclitaxel-eluting stents in patients undergoing percutaneous coronary intervention Am J Cardiol 98 2006 1563 1566
12. W.W. Chu, P.K. Kuchulakanti, R. Torguson, B. Wang, L.C. Clavijo, W.O. Suddath, A.D. Pichard, L.F. Satler, K.M. Kent, and R. Waksman Impact of overlapping drug-eluting stents in patients undergoing percutaneous coronary intervention Catheter Cardiovasc Interv 67 2006 595 599
13. M.H. Shishehbor, R. Amini, R.E. Raymond, A.A. Bavry, S.J. Brener, S.R. Kapadia, P.L. Whitlow, S.G. Ellis, and D.L. Bhatt Safety and efficacy of overlapping sirolimus-eluting versus paclitaxel-eluting stents Am Heart J 155 2008 1075 1080
14. A.S. Sharp, A. Latib, A. Ielasi, C. Larosa, C. Godino, M. Saolini, V. Magni, R.T. Gerber, M. Montorfano, M. Carlino, I. Michev, A. Chieffo, and A. Colombo Long-term follow-up on a large cohort of "full-metal jacket" percutaneous coronary intervention procedures Circ Cardiovasc Interv 2 2009 416 422
15. G.W. Stone, M. Midei, W. Newman, M. Sanz, J.B. Hermiller, J. Williams, N. Farhat, R. Caputo, N. Xenopoulos, R. Applegate, P. Gordon, R.M. White, K. Sudhir, D.E. Cutlip, and J.L. Petersen SPIRIT III Investigators. Randomized comparison of everolimus-eluting and paclitaxel-eluting stents: two-year clinical follow-up from the Clinical Evaluation of the Xience V Everolimus Eluting Coronary Stent System in the Treatment of Patients with de novo Native Coronary Artery Lesions (SPIRIT) III trial Circulation 119 2009 680 686
16. E. Kedhi, K.S. Joesoef, E. McFadden, J. Wassing, C. van Mieghem, D. Goedhart, and P.C. Smits Second-generation everolimus-eluting and paclitaxel-eluting stents in real-life practice (COMPARE): a randomised trial Lancet 375 2010 201 209
17. L. Räber, P. Jüni, E. Nüesch, B. Kalesan, P. Wenaweser, A. Moschovitis, A.A. Khattab, M. Bahlo, M. Togni, S. Cook, R. Vogel, C. Seiler, B. Meier, and S. Windecker Long-term comparison of everolimus-eluting and sirolimus-eluting stents for coronary revascularization J Am Coll Cardiol 57 2011 2143 2151
18. D.E. Cutlip, S. Windecker, R. Mehran, A. Boam, D.J. Cohen, G.A. van Es, P.G. Steg, M.A. Morel, L. Mauri, P. Vranckx, E. McFadden, A. Lansky, M. Hamon, M.W. Krucoff, and P.W. Serruys Academic Research Consortium. Clinical end points in coronary stent trials: a case of standardized definitions Circulation 115 2007 2344 2351
19. K.D. Dawkins, E. Grube, G. Guagliumi, A.P. Banning, K. Zmudka, A. Colombo, L. Thuesen, K. Hauptman, J. Marco, W. Wijns, J.J. Popma, N.J. Weissman, J. Koglin, and M.E. Russell Safety and efficacy of multiple, overlapping polymer-based paclitaxel-eluting stents EuroIntervention 3 2007 213 221
20. S.H. Her, K.D. Yoo, C.S. Park, D.B. Kim, J.M. Lee, P.J. Kim, H.Y. Kim, K. Chang, D.S. Jeon, W.S. Chung, K.B. Seung, and J.H. Kim Long-term clinical outcomes of overlapping heterogeneous drug-eluting stents compared with homogeneous drug-eluting stents Heart 97 2011 1501 1506
21. H. Otake, Y. Honda, M. Yamasaki, I. Tsujino, T. Shimohama, R. Sakurai, T. Hasegawa, K. Waseda, J. Ako, and P.J. Fitzgerald Vascular response to overlapping everolimus-eluting stents. Comparison with paclitaxel-eluting stents Circ J 74 2010 1023 1025
22. N. Mori, M. Nishino, D. Nakamura, Y. Lee, T. Yoshimura, M. Taniike, N. Nobuhiko Makino, H. Kato, Y. Egami, R. Shutta, H. Morita, J. Tanouchi, and Y. Yamada Different neointimal response to overlapping segments between everolimus-eluting stents and sirolimus-eluting stents - optical coherence tomographic study Circulation 124 2011 A12546
23. R. Jabara, S. Geva, H.B. Ribeiro, J.P. Chen, D. Hou, J. Li, S.B. King, N. Chronos, and K.A. Robinson A third generation ultra-thin strut cobalt chromium stent: histopathological evaluation in porcine coronary arteries EuroIntervention 5 2009 619 626
24. K. Kolandaivelu, R. Swaminathan, W.J. Gibson, V.B. Kolachalama, K.L. Nguyen-Ehrenreich, V.L. Giddings, L. Coleman, G.K. Wong, and E.R. Edelman Stent thrombogenicity early in high-risk interventional settings is driven by stent design and deployment and protected by polymer-drug coatings Circulation 123 2011 1400 1409
25. M. Joner, G. Nakazawa, A.V. Finn, S.C. Quee, L. Coleman, E. Acampado, P.S. Wilson, K. Skorija, Q. Cheng, X. Xu, H.K. Gold, F.D. Kolodgie, and R. Virmani Endothelial cell recovery between comparator polymer-based drug-eluting stents J Am Coll Cardiol 52 2008 333 342
26. H.H. Choi, J.S. Kim, D.H. Yoon, K.S. Hong, T.H. Kim, B.K. Kim, Y.G. Ko, D. Choi, Y. Jang, and M.K. Hong Favorable neointimal coverage in everolimus-eluting stent at 9 months after stent implantation: comparison with sirolimus-eluting stent using optical coherence tomography Int J Cardiovasc Imaging 28 2012 491 497
27. M. Takano, D. Murakami, M. Yamamoto, O. Kurihara, K. Murai, T. Inami, N. Kimata, T. Ohba, Y. Seino, and K. Mizuno Six-month follow-up evaluation for everolimus-eluting stents by intracoronary optical coherence tomography: comparison with paclitaxel-eluting stents Int J Cardiol 2011 Nov 8 [Epub ahead of print]